Day One Biopharmaceutical... (DAWN)

AI Score

Unlock

7.32

0.18 (2.52%)

At close: Apr 22, 2025, 3:59 PM

7.34

0.31%

After-hours: Apr 22, 2025, 06:42 PM EDT

Day One Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	124.97M	422.76M	239.62M	270.39M	230.78M	241.18M	189.21M	49.27M	85.26M	120.86M	388.88M	262.73M	284.31M	297.16M	310M	154.87M	43.73M	n/a
Short-Term Investments	406.75M	135.62M	122.25M	47.55M	135.56M	164.36M	253.67M	268.91M	257.01M	253.48M	5.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	121K	117K	117K	167K	214K	7.99M	259K	487K	469K	449K	484K	165K	169K	137K	126K	1.69M	107K	-27.33M
Receivables	13.88M	8.7M	9.14M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	3.32M	2.73M	151K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.37M	3.45M	7.61M	4.58M	2.35M	2.23M	781K	782K	1.01M	946K	839K	398K	1.01M	173K	174K	n/a	1.26M	n/a
Total Current Assets	562.33M	581M	383.16M	326.03M	375.27M	405.54M	449.78M	322.39M	347.87M	380.51M	402.5M	267.37M	289.37M	303.31M	316.02M	158.75M	45.07M	27.33M
Property-Plant & Equipment	4.71M	3.48M	360K	444K	560K	655K	713K	688K	719K	899K	1.06M	246K	284K	335K	386K	435K	483K	n/a
Goodwill & Intangibles	15.63M	16.22M	16.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.46M	19.81M	17.28M	611K	774K	8.64M	972K	1.18M	1.19M	1.35M	1.54M	411K	453K	472K	512K	2.13M	590K	-27.33M
Total Assets	582.79M	600.81M	400.44M	326.64M	376.05M	414.18M	450.76M	323.56M	349.06M	381.86M	404.05M	267.78M	289.82M	303.78M	316.54M	160.88M	45.66M	n/a
Account Payables	3.26M	3.02M	6.44M	4.78M	2.58M	3.39M	4.57M	4.66M	260K	3.97M	439K	701K	1.74M	683K	348K	686K	202K	n/a
Deferred Revenue	1.55M	1.46M	n/a	n/a	25.48M	20.24M	19.33M	n/a	n/a	n/a	11.77M	n/a	6.61M	4.98M	4.02M	2.17M	1.57M	n/a
Short-Term Debt	10K	77K	190K	n/a	408K	437K	428K	417K	n/a	462K	427K	171K	n/a	202K	201K	n/a	n/a	n/a
Other Current Liabilities	12.15M	23.61M	57.94M	874K	633K	-28K	-242K	14.54M	179K	8.33M	8.72M	5.49M	104K	-17K	508K	1.48M	27K	n/a
Total Current Liabilities	73.45M	39.74M	93.71M	29.84M	29.51M	24.48M	24.51M	22.85M	16.61M	18.27M	12.8M	8.18M	8.66M	6.05M	4.66M	3.07M	2M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	761K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	221.72M	91.96M	-25.32M
Total Long-Term Liabilities	6.59M	5.6M	n/a	n/a	n/a	77K	190K	300K	408K	514K	617K	872K	16K	65K	112K	221.88M	92.17M	-25.32M
Total Liabilities	80.04M	45.34M	93.71M	29.84M	29.51M	818.25M	24.7M	23.15M	17.02M	18.79M	13.42M	8.18M	8.67M	6.11M	4.77M	224.95M	94.16M	-25.32M
Total Debt	2.6M	2.62M	190K	300K	408K	514K	618K	717K	813K	976K	1.04M	171K	220K	267K	313K	358K	402K	n/a
Common Stock	10K	10K	9K	9K	9K	9K	9K	7K	7K	7K	7K	6K	6K	6K	6K	2M	2M	n/a
Retained Earnings	-554.08M	-488.37M	-525.4M	-521M	-458.58M	-404.07M	-357.92M	-312.06M	-269.67M	-229.56M	-191.76M	-155.23M	-127.49M	-105.55M	-86.31M	-72.02M	-56.84M	n/a
Comprehensive Income	84K	-6K	-22K	-5K	9K	-7K	-9K	67K	-71K	-392K	-3K	n/a	n/a	-303.78M	n/a	n/a	n/a	-10.67M
Shareholders Equity	502.75M	555.46M	306.73M	296.81M	346.54M	-404.07M	426.05M	-312.06M	332.04M	363.08M	390.63M	259.6M	-127.49M	297.67M	311.76M	-68.85M	-54.2M	25.32M
Total Investments	406.75M	135.62M	122.25M	47.55M	135.56M	164.36M	253.67M	268.91M	257.01M	253.48M	5.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a